Deployment Is Spreading Unevenly Across Quantum
Quantum is moving from testing toward deployment, with defense sensing already in early deployment. Commentary warns governments risk falling behind...
Created by Andy Harman
Quantum and medtech breakthroughs entering market, with funding and regulatory updates
Explore the latest content tracked by Quantum & MedTech Frontier
Quantum is moving from testing toward deployment, with defense sensing already in early deployment. Commentary warns governments risk falling behind...
The FDA's breakthrough designation for the investigational antibody daretabart is an expedited-development step, not an approval.
China's new five-year plan designates biotech a national "pillar industry" and aims to displace the U.S. as the leader. The article's author, from the...
The energy gap is stark: the Jupiter exascale system is cited at 15–20 megawatts, versus about 20 watts for the human brain. Most deep learning energy...
QUDORA has integrated NVIDIA CUDA-Q into its Qamelion emulator, letting developers write and test hybrid quantum-classical programs before its...
The company now targets 200 logical qubits as soon as 2030, double its earlier goal, using 3,600 physical cat qubits. Cat qubits suppress bit-flip...
Planckian's EIC Accelerator selection combines two parts with different status. The €2.5 million grant is part of the award and funds a 24-month...
Luda Technology's subsidiary AI Data Quant Tech signed a strategic cooperation framework agreement on November 17, 2026 with Shenzhen Zhicheng...
Based on Microsoft content, Majorana 2 is claimed to deliver a 1,000-fold reliability improvement over its predecessor. The change comes from swapping...
The FDA has granted accelerated approval to neladalkib for adults with previously treated, locally advanced or metastatic ALK-positive NSCLC. Eligible...
The unveiling of IBM's Quantum System 2 in Chicago is being framed around local workforce goals.
Vertex's povetacicept decision for IgA nephropathy is expected on or before Nov. 30. Analysts say it could open a next chapter for the company, as...
BlueQubit's Quantum Flywheel awards $10,000 to $40,000 per team, drawn from a $150,000 program. The grants point research in specific directions:
-...
A new Mind Commerce analysis points to strong investor interest in quantum computing, though its evidence is mostly forward-looking.
A newly approved treatment may slow damage to insulin-producing cells, but the window to act is short.
Two recent announcements suggest quantum's practical path may depend as much on software as on hardware. Q-CTRL says it has unified Boulder Opal and...
Moroxite has received its second FDA Breakthrough Device Designation, this one for Xerafuse TOB, a tobramycin-eluting resorbable bone graft...
Quantum-HPC work is moving past one-off demos in a few concrete areas:
There is still no cure for spinal cord injuries, but two promising treatments are being studied in Chicago. The Scherb family founded BreakThru SCI...